Spyre Therapeutics Inc. Dividends
The next dividend date for Spyre Therapeutics Inc. has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Spyre Therapeutics Inc. (SYRE)
More About Spyre Therapeutics Inc.
Spyre Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD). It develops SPY001, a human monoclonal immunoglobulin G1 antibody designed to bind selectively to the a4ß7 integrin being developed for the treatment of IBD (ulcerative colitis and Crohn's disease). The company is developing SPY002, a human monoclonal antibody (mAb)candidates designed to bind to tumor necrosis factor-like ligand 1A; and SPY120, a combination of SPY001 (anti-a4ß7) and SPY002 (anti-TL1A) antibodies, which are in preclinical studies. In addition, its other early-stage programs include SPY003, an anti-IL-23 mAb; SPY004; SPY130, a combination of anti-a4ß7 and anti-IL-23 mAbs; and SPY230, a combination of anti-TL1A and anti-IL-23 mAbs. The company was formerly known as Aeglea BioTherapeutics, Inc. and changed its name to Spyre Therapeutics, Inc. in November 2023. The company was incorporated in 2013 and is based in Waltham, Massachusetts.
Owning Spyre Therapeutics Inc. Stock on the Dividend Date
If you own Spyre Therapeutics Inc. stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Spyre Therapeutics Inc. stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Spyre Therapeutics Inc. stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Spyre Therapeutics Inc. stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Spyre Therapeutics Inc. dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Spyre Therapeutics Inc. Dividends
You can contact us any time if you would like to ask questions about Spyre Therapeutics Inc. dividends or anything else related to the stock market.